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We report here, for the first time, two cases demonstrating a synergistic application of
bilateral cardiac sympathetic decentralization and multimodal psychiatric treatment for
the assessment and management of anxiety following recurrent Implantable Cardioverter
Defibrillator (ICD) shocks. In a first case the combination of bilateral cardiac sympathetic
decentralization (BCSD), cognitive behavioral psychotherapy and anxiolytic medication
was sufficient to attenuate the patient’s symptoms and maladaptive behaviors, with a
maintained benefit at 1 year. Among the more prominent subjective changes in the
post-lesion state we observed a decrease in aversive interoceptive sensations, particularly
of the heartbeat. The patient continued to experience cognitive threat appraisals on a
frequent basis, although these were no longer incapacitating. In a second case, we report
the effect of BCSD on autonomic tone and subjective state. In the post-lesion state we
observed attenuated sympathetic responses to the valsalva maneuver, isometric handgrip
and mental arithmetic stressor, including decreased systolic and diastolic blood pressure
and, decreased skin conductance. Collectively, these preliminary findings suggest that
an integrative, multidisciplinary approach to treating anxiety disorders in the setting of
ventricular arrhythmias and recurrent ICD shocks can result in sustained improvements
in physical, psychological, and functional status. These findings raise the possibility of
a potential role for the stellate ganglion in the modulation of emotional experience and
afferent transmission of interoceptive information to the central nervous system.
Keywords: autonomic nervous system, stellate ganglion, anxiety disorders, implantable cardioverter defibrillator,
electrical storm, interoceptive awareness, PTSD, cognitive behavioral therapy
BACKGROUND
Implanted Cardioverter Defibrillator (ICD) placement generally
occurs when a patient with certain types of cardiovascular dis-
ease, including cardiac arrhythmia, structural heart disease, heart
failure or history of Sudden Cardiac Arrest (SCA), is judged to
be at increased risk of fatal arrhythmias without intervention
(Epstein et al., 2008; Tracy et al., 2012). Although this interven-
tion has a well demonstrated survival benefit (Moss et al., 1996;
Maron et al., 2000; Corrado et al., 2003), it is associated with a
host of psychological sequelae in pediatric and adult populations
that are often incompletely addressed at the time of implan-
tation (Sears et al., 1999, 2009, 2011; Sears and Conti, 2002;
Hazelton et al., 2009; Dunbar et al., 2012). The most significant
among these appears to be the occurrence of repeated and unpre-
dictable defibrillator shocks, whether appropriate (i.e., discharge
in the presence of a detected arrhythmia; occurring in 17–64%
of patients) or inappropriate (i.e., discharge without presence of
detected arrhythmia; occurring in 10–24% of patients) (Sears and
Conti, 2003; Germano et al., 2006).
ICD discharge, whether appropriate or inappropriate, poses
a particularly challenging psychological event that can condi-
tion patients to become fearful in their search for an explana-
tion. Prominent features include the maladaptive development of
hypervigilance toward interoceptive cues, fear and avoidance of
interoceptive sensations, avoidance of physical and mental situa-
tions that might trigger interoceptive sensations, and attachment
to objects or people perceived to assure safety (i.e., safety seek-
ing). This cycle of events, which we have described previously
(Bystritsky et al., 2013), drives psychiatric comorbidity and con-
tributes to disorders such as Panic Disorder, Post-Traumatic Stress
Disorder, and Social Anxiety disorder, sometimes all within the
same individual. Ultimately, between 11 and 38%of these patients
are estimated to develop anxiety disorders and between 11 and
46% to develop major depression (Magyar-Russell et al., 2011;
Dunbar et al., 2012).
Although anxiety related to ICD implantation and discharg-
ing may be mild or transient, for some patients it can lead to
long lasting debilitating behavioral changes. For example, one
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cardiomyopathy patient began spending all of his time in his local
hospital after receiving recurrent ICD shocks, under the ratio-
nale that this was the safest place to be to avoid further harm.
He remained in these areas of the hospital for several months
and experienced significant fear upon leaving. Due to contin-
ued worry about being shocked, the patient even obtained a
stethoscope in order to better listen to his heartbeat. When he
noticed his heart racing he would auscultate it with the stetho-
scope, claiming he could distinguish between normal tachycardia
and tachycardia associated with his arrhythmia, and predict the
onset of a shock approximately 3 seconds later. Another patient
refused to shower alone for 3 months, out of fear that he would be
shocked by his ICD, become incapacitated, and no one would find
him. This same patient remained within a three mile radius of his
home for 1 year, because it was located near a hospital, for fear
that he would be shocked and would not be able to be evaluated
and resuscitated in time.
These patient experiences and the overall psychological burden
of ICDs suggest that a comprehensive assessment and treatment
plan involving medical and psychiatric intervention is warranted,
particularly for the most severely affected individuals. We report
here, for the first time, the results of a synergistic application
of bilateral cardiac sympathetic decentralization (BCSD) and
multidimensional psychiatric treatment resulting in successful
management of anxiety following ICD multiple shock storm. We
present a detailed description of the physical and psychological
responses to BCSD with up to 1 year of follow up, in two patients.
We examined the effect of BCSD on autonomic tone in both
patients, using specific tasks shown to directly activate the medial
visceromotor network, including the anterior cingulate cortex
(ACC) and medial prefrontal cortex (King et al., 1999; Critchley
et al., 2000; Wong et al., 2007; Gianaros et al., 2012; Shoemaker
et al., 2012). However, as we were unable to obtain pre-lesion
data from one patient (Case 1), we report only the effects of such
testing before and after BCSD in the other patient (Case 2).
To measure shock related cognitive threat appraisals
we adapted a scale from the pain literature, the Pain
Catastrophization Scale (Sullivan et al., 1995). This scale
was designed to measure several cognitive distortions associated
with chronic pain including magnification, rumination, and
helplessness. We adapted this scale as we believe these phenomena
are commonly present during the experience of chronic anxiety
related to painful and distressing ICD shocks, and have renamed
it the Shock Catastrophization Scale (SCS) (see Appendix for full
scale details including reliability analysis).
CASE 1
HISTORY OF PRESENT ILLNESS
The patient was a 38 year-old healthy male without a history
of cardiovascular or psychiatric disease who experienced a sud-
den collapse while bicycling to work. On primary assessment
by paramedics he was found to be pulseless. Cardiopulmonary
resuscitation was initiated. He was electrically cardioverted, resus-
citated, and rushed to the nearest hospital. To preserve cerebral
function, the patient was placed in an induced hypothermic and
comatose state. During his recovery he experienced an episode
of ICU delirium with agitation resulting in administration of
sedative medication. After recovering from this delirium, he
reported discrete retrograde memory loss from 1 day prior to
the event through the first week after his SCA. He underwent
ICD implantation (dual lead, atrial and ventricular, Medtronic
Inc. St Paul, MN) at 2 weeks for secondary prevention of sudden
death, and was discharged from the hospital shortly afterwards.
He returned to work 3 weeks after the event. Immediately after
ICD implantation the patient described being very fearful of
being alone in the house with his young children. In response,
he and his wife developed procedures to ensure that their chil-
dren knew how to call emergency medical services if he were to
become unresponsive or be shocked.
The patient experienced his first ICD shock 11 months later,
while riding the exercise bike at a local gym. He received a total
of 6 shocks over approximately 2–3min. After realizing he was
being shocked, he did not recall experiencing anxiety. Rather, he
described responding calmly and without terror, in a way that did
not distract or alert others to his experience (i.e., no social dis-
ruption). In the patient’s words: “they had told me it would feel
like getting kicked in the chest by a horse. It didn’t really feel like
that. It was just a very loud, like a ‘thunk!’ sound. I maintained con-
sciousness. At first I wasn’t sure what it was. By the time the second
one came, I realized this must be the defibrillator going off. And I was
conscious the whole time, and walking. I don’t know what the inter-
val was, probably I guess 15–20 seconds in between [each shock].”
Patient’s wife: “you weren’t very fazed by it though, and nobody else
knew what was happening.” Patient: “Right. And that goes to some
of my anxiety, and why some of the subsequent shockings impacted
me more than that one. This one I was able to keep private. Nobody
knew what was happening. I knew I got shocked. I went home, called
my doctor. It wasn’t a very big public scene.”
The patient experienced his second episode of repeated ICD
shocks while at the gym, after 15min of jogging on the tread-
mill. He received a total of 7 shocks approximately 20 s apart.
He again denied experiencing any social disruption, but this
time felt terror over the lack of control over his symptoms. He
also described experiencing physical pain with the shock. In the
patient’s words: “It’s not so much the pain of the shock as much
as, is there another one coming? Is this the last one, or am I brac-
ing for another one? I’m trying to calm down, to get my heart rate
down, but it’s almost impossible because I’m under this utter terror
that another one is coming, and another one, and is it ever going to
stop?”
During this second set of shocks, despite the reported fear and
aversive anticipation of subsequent shock, he denied experiencing
thoughts of death. When asked how he considered the meaning of
the shocks, he stated “I’m not afraid I’m going to die, I don’t feel like
this event is going to kill me. At that time I’m more concerned with
‘will it stop? How can I make it stop, and who is going to help me
make it stop?’ I feel somewhat powerless in this whole sequence of
being subjected to these shocks, with really no ability to make it stop
at some point. That’s what impacts me most when it’s happening.”
He further noted: “When I got my defibrillator originally, I remem-
ber this distinctly, my doctor told me ‘You’re gonna die some day. But
it’s not going to be from this. You’ve got the defibrillator now, you’re
not going to die from this.’ And I certainly took some comfort from
that.”
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After uploading data from the ICD to his cardiologist, which
demonstrated a ventricular tachycardia progressing to ventricu-
lar fibrillation, he was referred for further treatment via cardiac
catheter ablation procedure to target a focus of premature ven-
tricular contractions (PVCs) that had been previously identified.
He also underwent an atrial lead revision and generator change
during a separate procedure.
After the second set of shocks, the patient became preoccu-
pied with the potential impact the shocks might have on his social
milieu, a fear that “I’m gonna get shocked in front of other people
and they will think I’m defective.” He developed several avoidance
behaviors. He stopped exercising or engaging in all activities that
could potentially increase his heart rate (including sex), under
the belief that this would cause him to experience another shock.
Hypervigilance emerged: he began scanning his body for signals
that could predict a shock, such as feeling a fast heartbeat, or a
“not good” feeling. He began to seek further reassurance that he
was unlikely to receive another shock, by frequently contacting
his cardiologist and frequently monitoring his ICD’s electronic
output. During each of these visits, no abnormalities were found.
Two and a half years after receiving his first shock, the patient
reported being shocked “in a different way.” While out of town
and walking with some co-workers, he received a shock and fell
to the ground, grunting and groaning. There was no loss of
consciousness. He continued to receive a total of 8 shocks in
a row. Paramedics arrived at the scene and administered anx-
iolytic benzodiazepines, which the patient believes aborted the
shocks. He was hospitalized for 4 days. Interrogation of his
ICD revealed he had received appropriate ICD discharges in
response to the spontaneous development of ventricular tachy-
cardia. There were no further abnormal findings on electrophys-
iological exam, and he was discharged without application of
any specific procedures or medications. This experience affected
the patient differently, because “I could no longer hide it. There’s
shame involved, [that] there’s something wrong with me.” The
lack of specific treatments rendered further anxiety. Riding home
alone on the airplane he was extremely anxious about being
shocked again, without access to emergency medical services. He
experienced his first panic attack in midair, with prominent dys-
pnea, palpitations, dizziness, and fear of losing control over his
mind and body. He also worried that being shocked in front
of other people would cause them to think he was defective.
After arriving home safely, he began to experienced recurrent
panic attacks, approximately 10–15 times per month. These were
often provoked when in open or crowded spaces, and so he
began avoiding them. He began to avoid conversations while
walking, “because that’s what I was doing when I got shocked.”
He also experienced several spontaneous attacks without a clear
trigger.
Due to continued distress from these symptoms, the patient
established his first contact with a mental health provider 3
years and 9 months after receiving his first shock. He began
counseling treatment with a licensed clinical social worker,
every 2 weeks, for a total of 6 visits. He learned basic relax-
ation techniques including deep abdominal breathing. Other
elements of the treatment, in the patient’s words included: “He
told me how to deal with the shame of the event, by telling
people around me what could happen, what they should do.
He told me that if I told more people about it, I wouldn’t
be as concerned about the public spectacle.” The patient did
not receive any psychiatric evaluation or other forms of
treatment.
A week and half prior to psychiatric evaluation at UCLA, and
nearly 4 years after his initial SCA, the patient received his fifth set
of ICD shocks while at work. During a meeting he had a “premo-
nition” and began to feel anxious about being shocked. He began
to feel “not good,” felt his heart beating faster and “I knew that
a shock was coming.” After receiving his third shock, he told a
coworker to call emergency medical services. He received a series
of 13 shocks over a period of minutes. He recalls that when the
paramedics arrived and administered IV lorazepam, the shocks
seemed to stop. He was again hospitalized for medical evalua-
tion. According to his wife, he would often receive intravenous
lorazepam for anxiety, particularly prior to his physicians’ arrival
for morning rounds, and was discharged with a prescription to
take this on an as needed basis.
Based on the pattern of recurrent ICD shocks, the patient
was referred by his cardiologist for consideration for BCSD at
UCLA. He underwent this procedure the day after his psychiatric
evaluation.
PAST MEDICAL AND SURGICAL HISTORY
In addition to experiencing SCA, the patient had been diag-
nosed with a polymorphic ventricular tachycardia, undergone a
dual lead ICD implantation. Surgical procedures included cardiac
catheter ablation for PVCs, atrial lead and generator replacement,
right shoulder dislocation with subsequent shoulder surgery, and
appendectomy.
SOCIAL, FAMILY, EDUCATIONAL, OCCUPATIONAL, AND SUBSTANCE
USE HISTORY
The patient received a bachelor’s degree in computer engineering
and was currently employed as an engineer in a hardware design
firm. There was no history of developmental disabilities. He was
married, with two children. He denied any history of abuse or
arrests. In reference to his early social life, he described himself
as an “awkward teenager,” whose friendships were mainly with
“outcast kids.” The patient reported a brief period of marijuana
use in college, but otherwise denied any regular alcohol, tobacco
or illicit substance use. Family history was notable for a myocar-
dial infarction (paternal grandfather), and alcohol dependence
(uncle). There was no other family history of psychiatric illness,
and no family history of suicide.
MEDICATIONS
At the initial evaluation, the patient was prescribed the follow-
ing medications: lorazepam 1mg BID prn (patient reported using
2mg BID for the prior 10 days), metoprolol 10mg BID, verapamil
120mg BID, and aspirin 81mg daily.
DIAGNOSTIC IMPRESSION AND CLINICAL SEVERITY
After undergoing a structured clinical interview utilizing MINI
International Neuropsychiatric Interview (Sheehan et al., 1998),
the patient met DSM IV-TR diagnostic criteria for Post-
Traumatic Stress Disorder, Panic Disorder with Agoraphobia, and
Social Anxiety Disorder. There was no evidence of axis II pathol-
ogy. Symptom severity was assessed using several quantitative
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clinical measures. These indicated “severe” levels of general anx-
iety (via Beck Anxiety Inventory, BAI (Beck and Steer, 1990),
“markedly ill” levels of panic (via Panic Disorder Severity Scale,
PDSS) (Furukawa et al., 2009), and borderline clinical depres-
sion (via Beck Depression Inventory, BDI) (Beck and Steer, 1993)
(Table 1).
TREATMENT COURSE
In an attempt to reduce susceptibility to recurrent ventricular
tachycardia, partial sympathectomy via BCSD has been applied
in selected treatment refractory patients at UCLA (Ajijola and
Shivkumar, 2012; Ajijola et al., 2012; Vaseghi et al., 2012, 2013).
Bilateral cardiac sympathetic lesioning decreases sympathetic
efferent noradrenergic innervation to the heart, and putatively
mitigates the pro-arrhythmic effects of sympathetic innervation
(Ajijola et al., 2012). The patient underwent this procedure,
consisting of a resection covering the lower half of the stellate
ganglion and the bodies of sympathetic chain from T2 through
T4. He has been followed for approximately 1 year.
Immediately after recovering from the surgery, the patient
reported continued episodes of anxiety, including one noctur-
nal panic attack. He continued utilizing lorazepam 2mg daily as
needed for anxiety, but during these episodes noted “I couldn’t
feel my heart racing.” After 2 weeks, he continued experiencing
anxiety that “comes and goes.” He was still using lorazepam as
needed, approximately every 2–3 days. He had not experienced
any further panic attacks.
After 1 month, the patient had returned to work and reported
“I’m starting to feel better.” However, he avoided his first work
meeting by calling in from home, and still endorsed “a lot of anx-
iety” related to being in situations where he had been shocked
previously, including work. When he did eventually attend a
work meeting with a colleague, he denied experiencing anticipa-
tory sensations as before, including the absence of a rapid pulse,
causing the patient to spontaneously note “I have noticed differ-
ences in how my body reacts.” When referring back to his home
vital sign monitoring records, he reported that his average heart
rate had decreased from the 80’s to 65. Quantitative examination
of his psychiatric symptoms at this time compared to prior to
BCSD revealed an unchanged level of general anxiety (via BAI)
and slightly decreased intensity of panic (via PDSS) (Figure 1).
Based on these continued symptoms, he was referred for cognitive
behavioral therapy (CBT) with a PhD psychologist specializing in
treatment of PTSD.
At 1 month he reported experiencing a single atypical shock.
In the patient’s words: “when leaving work today I was fixing some-
thing on the floor.When I stood back up I did not feel right. Not dizzy
just felt that something was not right. I took a sip of water to try and
calmmyself but the feeling did not go away. I walked downstairs and
the sensation got stronger. Then I got a single shock. Seemed more
mild than others. After the shock I had a real difficult time calm-
ing my body down as with prior incidents. Despite this I did not
receive a cascade of shocks. Perhaps the benefit of the procedure—
stopping my body reaction from impacting the ability of the heart to
return to normal rhythm. Despite my panic, I only received a sin-
gle shock. In the past my inability to calm myself down would result
in multiple shocks usually until EMS arrived and administered a
calming medication.” Analysis of his ICD data showed a fast ven-
tricular tachycardia that was different from previously observed
ventricular fibrillation. It was felt that this could be due to post-
lesion cardiac remodeling. He was started on amiodarone 200mg
BID.
Three months after undergoing BCSD, the patient reported
he was “doing better.” He was receiving weekly psychotherapy via
CBT and had completed 8 sessions. He was learning “more aware-
ness of what anxiety is and what a panic attack is.” He was also
FIGURE 1 | Time course of psychiatric symptom rating for case 1
during 1 year follow up. BDI, Beck depression Inventory; BAI, Beck
Anxiety Inventory; PDSS, panic Disorder Severity Scale; PCL, PTSD Check
list; SCS, Shock Catastrophizing Scale; FSAS, Florida Shock Anxiety Scale.
Note the increase in reported PTSD symptoms (via PCL civilian) at 1-year
anniversary of worst shock episode, accompained by a moderate score on
the Florida Shock Anxiety Scale (typical mean for ICD patient = 15.2,
standard deviation = 6.5; from Ford et al., 2012).
Table 1 | Psychiatric symptom ratings for Case 1 during 1 year follow-up.
Scale Pre-BCSD 1 month post 3 months post 6 months post 9 months post 1 year post
BDI (max 63) 18* 14* 17* 10 10
BAI (max 63) 27* 27* 13* 6 2 4
PDSS (max 28) 21* 16* 13* 8* 6 2
PCL civilian (range: 17–85) 33 35 31 46*
SCS (max 52) 30* 16 15
FSAS (range: 10–50) 32*
*Indicates scores in a clinically significant range based on scoring criteria for each instrument. BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; PDSS,
Panic Disorder Severity Scale; PCL, PTSD Checklist—Civilian version. SCS, Shock Catastrophizing Scale; FSAS, Florida Shock Assessment Scale.
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learning different strategies to cope with and manage his anx-
iety, including advanced deep breathing techniques and guided
pre-recorded audio meditations. He had not started exposure and
response prevention, a common and effective behavioral compo-
nent of CBT, but had begun discussing this approach with his
therapist. He reported experiencing continued panic attacks 1–2
per week, but felt these were less severe, and of shorter dura-
tion (1–2min in duration vs. 10min). In addition, he continued
to note “I don’t feel my heart rate like I did during anticipation
of shock. I also don’t feel PVCs as much as I used to.” Although
he reported walking more, he was still avoiding most meetings
by calling in sick, and avoiding going to the gym. Due to his
continued symptoms he had been referred to a psychiatrist, had
been prescribed a low dose of an SSRI, sertraline, initially 12.5mg
daily and up to 25mg daily at the time of contact. He contin-
ued taking lorazepam on an as-needed basis, but at a lower dose
of 1mg daily three to four times per week. Quantitative review
of his symptoms now demonstrated a nearly 50% drop in gen-
eral anxiety down to a ‘mild’ level (via BAI), a continued decrease
in panic severity (via PDSS), and a small but clinically insignif-
icant decrease in depression (via BDI; Figure 1). He had not
experienced any further shocks, and no further ICD events were
detected.
Six months after undergoing BCSD, the patient continued
receiving weekly psychotherapy. He had begun conducting pro-
longed exposures, a common treatment for psychotherapeutic
treatment of PTSD, tailored toward the experience of being
shocked. These pertained to “the memories of the two most sig-
nificant shock events that have been very difficult for me to think
or talk about. I discuss the memory in detail and record it on my
phone and then listen to the recording multiple times. It has helped
a lot and I no longer have a significant reaction to thinking about
those memories.”He stated he was no longer avoiding going to the
gym, and was no longer avoiding individual meetings at work.
He continued to express concern about attending groupmeetings.
Sertraline had been increased to 150mg daily. He noted difficulty
“to differentiate the benefits of the sertraline and [psychotherapy].”
He had not experienced any further shocks, and no further ICD
events were detected. In reviewing his progress, he spontaneously
noted, “all in all, I have improved significantly from last fall and
I can see a day when I will return to my prior self.” Quantitative
review of his symptoms now demonstrated a nearly 50% drop in
general anxiety (via BAI) and a continued decrease in panic sever-
ity (via PDSS), with a small but clinically insignificant increase in
depression (via BDI; Figure 1).
Nine months after undergoing BCSD, the patient reported
“I have been feeling a lot better lately.” He continued seeing his
therapist but on a slightly decreased basis, weekly to bimonthly.
His sertraline had been increased to 200mg daily. He contin-
ued to refrain from utilizing lorazepam. He had not experienced
any further shocks, and no further ICD events were detected.
Quantitative symptom review revealed that most of the patient’s
symptoms had continued declining. His general anxiety level was
in the “very low” range, and symptoms of panic were now in the
“borderline ill” range (Furukawa et al., 2009). His depression was
now in the non-clinical range of “normal ups and downs.”
The patient summarized his progress at 9 months as follows:
“At times not even thinking about my condition. Previously, it was
a constant thought - constant polling of my body to make sure I
felt ok. There have been days where I have felt completely normal.
I’m now getting active again. Starting on the treadmill. A remain-
ing fear is associated with activity and getting my heart rate up.
Breathing hard is especially a trigger that I have avoided. The dif-
ference now is that I no longer view getting on the treadmill as
impossible. I feel like I can do it—gradually. Feeling better in social
situations also. Had an impromptu lunch with two colleagues last
week. Felt good for the entire lunch and participated in conversa-
tion and started some conversations. Previously, I had avoided this
type of situation. I did have one episode yesterday that caught me off
guard. At the end of a meeting we were talking about general things.
We were talking about injuries and one person mentioned my SCA
[Sudden Cardiac Arrest]. Everyone there knew about my history but
one. I have talked about it recently without issue. However, after
I started telling the story of my original SCA I had a very strong
sensation—rushing feeling like someone is cranking up the volume
inside my body. I tensed up expecting a shock. No shock occurred but
I got up and returned to my desk and relaxed to decrease my pulse
rate.”
1 year after undergoing BCSD the patient’s anxiety, panic
and depression symptoms remained markedly attenuated, and in
non-clinical ranges (Figure 1). He continued psychotherapy at a
further decreased frequency, once permonth, and anticipated dis-
continuing this soon afterwards. He continued on an unchanged
dose of sertraline, 200mg daily. He no was no longer utilizing
lorazapam. Other medications included verapamil 120mg BID,
metoprolol 50mg daily, and aspirin 81mg daily. His cardiolo-
gist had tapered and discontinued amiodarone 1 week before. He
had not experienced any further shocks. Review of his ICD data
showed no events over the past 6 months, which was the “first
time that has ever happened since my initial arrest.” This informa-
tion was particularly “surprising,” as this objective record failed
to corroborate the subjective diary records of the exact dates and
times when he had perceived the body sensations of an abnormal
event during that time period.
In subjectively reviewing his symptoms 1 year after BCSD, the
patient noted “I’m starting to have days were I do not constantly
think about whether a shock is imminent. I no longer struggle and
avoid social situations.” He noted the lingering presence of cogni-
tive threat appraisals: “I do still encounter thoughts of playing out
scenarios of what would happen if my defibrillator went off—who
would see, what would happen. This happens when I’m in social sit-
uations especially when walking. I do very occasionally have episodes
of what I call an ‘attack.’ Basically, having a physical sensation that
mimics the feeling that I get right before a shock. It is like a rushing
feeling—tensing up in my body—bracing for the shock. When that
happens I usually quickly excuse myself from the situation and calm
down and the ‘attack’ passes.”
He reported further decreased avoidance of exercise: “I have
started walking on the treadmill on a regular basis. Fast walk-
ing. Enough to sweat—about 40min. However, I make a conscious
effort to control my breathing and not let my pulse rate get ele-
vated.”Despite his increased exercise capacity, at 1 year the patient
reported he had sustained a 50 pound weight gain. He also
endorsed continued preoccupation with receiving a shock dur-
ing physical exertion: “The one remaining aspect of my treatment
is dealing with my fear of activity. I’m terrified that elevating my
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heart rate will result in a shock. Frankly, I don’t think I will ever
move past this fear. The times I have been shocked my pulse has
been high. The procedure effectively lowered my pulse rate. So logic
leads me to thinking that if the procedure lowers my heart rate then
why would I increase it purposefully.” Exactly 1 year after his worst
shock episode, these preoccupations were reflected by moderately
elevated scores on the SCS and FSAS, and clinically significant
scoring on the PCL (Figure 1).
SIDE EFFECTS OF BCSD
The patient did not experience Horner’s Syndrome, an occasional
occurrence with stellate ganglion nerve blocks (Schürmann et al.,
2001; Lipov, 2010). This was due to the selectivity of the patient’s
lesion, which spared the caudal head of the stellate ganglion,
a region carrying sympathetic nerve fibers to the eye and face.
The patient did report the subsequent absence of sweating of the
palms and head, and development of hyperhidrosis of the trunk
and legs, which have been described as compensatory responses to
the severing of sympathetic nerve fibers to the trunk (Hashmonai
et al., 2000; Drott et al., 2002).
DETAILED ANALYSIS OF ANXIETY SYMPTOMS:
Subscale examination of the patient’s anxiety revealed several
notable patterns (Figure 2, Table 2). During the 2 weeks after
undergoing BCSD, the patient reported an overall increase in
feeling bothered by several cognitive and interoceptive compo-
nents of anxiety. The former may have been related to uncertainty
about receiving future shocks, and concern about the successful-
ness of the surgery. The latter may have been related to post-lesion
remodeling within the autonomic nervous system that can result
in the symptoms of heat sensations, flushing and difficulty breath-
ing reported by the patient. Despite these increases, the patient
reported decreases in feeling bothered by dizziness and lighthead-
edness, and a reduction in feeling bothered by the experience of
his heart pounding and racing (Figure 3). Both of these decreases
appeared clinically significant, i.e., the symptoms decreased from
the maximum score (“severely—it bothered me a lot”) to a mild
score (“mildly but it didn’t bothermemuch”). Furthermore, these
reductions were sustained throughout the year. In the case of
heartbeat sensations, at 1 year the patient reported a complete
cessation of symptoms (Figure 3). The only other symptom that
declined with a similar magnitude was the feeling of being scared,
which decreased entirely between 2 weeks and 3 months after the
procedure. Of note, this timeframe corresponded to the initiation
of CBT, and formation of a therapeutic bond with his psycholo-
gist. It seems unlikely this drop was due to pharmacotherapy, as
the patient was no longer utilizing benzodiazepines at that time
and had only recently initiated a subtherapeutic dose of sertraline
(25mg daily).
The patient also demonstrated a decline in shock related catas-
trophic thinking (via SCS) between 6 and 9 months post-lesion.
This timeframe corresponded to completion of the majority of
his CBT visits, and also to the titration of sertraline to a therapeu-
tic dose. Given the concomitant nature of both interventions, is
therefore difficult to distinguish which was more likely respon-
sible for the decrease in catastrophizing symptoms during that
timeframe.
FIGURE 2 | Time course of Beck Anxiety Inventory somatic, cognitive
and interceptive symptoms in Case 1.
With regard to symptoms of PTSD assessed via PCL, the
patient demonstrated low-moderate scores between 3 and 9
months, which were in the non-symptomatic range via scor-
ing criterion 2 (Blanchard et al., 1996). Exactly 1 year after the
patient’s last episode of ICD shock storm, the patient’s PCL
score increased into the symptomatic range. Similarly, at 1 year
the patient’s score on the FSAS was in the moderate range.
Subsequent inquiry revealed that the patient was quite aware of
this epoch, and had been thinking about his last shock episode
during the days and weeks leading up to this anniversary event.
He also explained that he had recently began pushing the lim-
its of his exercise comfort level as a part of his exposure and
response prevention psychotherapy, which is known to temporar-
ily increase anxiety levels (Craske and Barlow, 2007). It is possible
that his FSAS score could have been decreased (or elevated) prior
to this time period, but this remains speculative as this data was
unavailable for earlier time points.
CASE 2
HISTORY OF PRESENT ILLNESS
The patient was a 23 year old female with a history of recurrent
syncope and suspected seizure disorder who experienced a SCA
associated with loss of consciousness while at work during ameet-
ing. She was externally defibrillated by members of the local fire
department, and taken to a local hospital where she was found
to have a prolonged corrected QT interval of 560ms. She was
diagnosed with idiopathic ventricular fibrillation vs. possible long
QT syndrome. Five days after presentation, a dual chamber single
coil ICD (Medtronic Inc., St. Paul, MN) was placed for secondary
prevention, and she was discharged following a 1 week hospital-
ization. Three months later, she experienced her first ICD shock.
She was sitting down, and began to feel lightheaded, then lost
consciousness. She was shocked a total of three times, though
she does not remember this. Upon waking, she noticed a pain in
the anterior chest radiating to her arm. Interrogation of her ICD
revealed she had also received an appropriate shock for an episode
of ventricular fibrillation while asleep several days earlier, though
she had nomemory of this. Device interrogation revealed that the
patient had exhibited antitachycardia pacing during defibrillator
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Table 2 | Somatic, cognitive and interoceptive anxiety symptoms in Case 1 during 1 year follow-up, from the Beck Anxiety Inventory (BAI).
BAI subscale Pre BCSD 2 weeks post 3 months post 6 months post 9 months post 1 year post
SOMATIC
Numbness/tingling 2 2 0 0 0 0
Leg wobbliness 1 0 0 0 0 0
Dizzy/lightheaded 2 0 0 0 0 0
Unsteady 1 0 0 0 0 0
Hands trembling 1 2 2 1 0 0
Shaky/unsteady 1 0 0 0 0 0
Faint/lightheaded 2 0 0 0 0 0
Total somatic 10 4 2 1 0 0
COGNITIVE
Can’t relax 0 2 1 1 0 1
Fear worst 0 3 2 1 0 0
Terrified/afraid 2 2 1 0 0 0
Nervous 2 2 0 0 0 1
Fear dying 0 0 0 0 0 0
Scared 3 3 0 0 0 0
Losing control 2 1 2 1 0 1
Total cognitive 9 13 6 3 0 3
INTEROCEPTIVE
Hot 2 3 1 0 0 1
Heart pounding/racing 3 1 1 1 1 0
Choking 0 0 0 0 0 0
Difficulty breathing 1 2 1 0 0 0
Indigestion 0 1 1 0 1 0
Flushed face 2 2 1 0 0 0
Hot/cold sweats 0 1 0 1 0 0
Total interoceptive 8 10 5 2 2 1
Scale: 0, “not at all.” 1, “mildly, but it didn’t bother me that much.” 2, “moderately—it wasn’t pleasant at times.” 3, “severely—it bothered me a lot.”
charging, which had disorganized the ventricular tachycardia into
polymorphic ventricular tachycardia and ventricular fibrillation.
She was hospitalized for defibrillator threshold testing, in order
to ascertain the likelihood that her ICD could successfully termi-
nate a sustained ventricular tachyarrhythmia. Unfortunately, due
to a high defibrillation threshold, 6 attempts to elicit ventricular
tachycardia termination were unsuccessful. To decrease the risk
of recurrent ventricular arrhythmias requiring ICD shocks, the
patient was referred for consideration of BCSD.
PAST MEDICAL HISTORY
Notable for recurrent syncopal episodes with loss of conscious-
ness dating back to high school. On one occasion she may have
been noted to bite her tongue, prompting a diagnosis of a seizure
disorder, and prescription of phenytoin. There was no history
of neurological workup including electroencephalogram (EEG).
Nine months prior to first SCA, the patient had a successful
vaginal delivery without complications.
SOCIAL, FAMILY, EDUCATIONAL, OCCUPATIONAL, AND SUBSTANCE
USE HISTORY
The patient was employed as an assistant restaurant manager.
She was married with a 1 year-old daughter. She had received an
associates degree in culinary arts. There was no family history of
psychiatric illness or cardiovascular disease or syncope or sudden
death. No history of substance abuse.
MEDICATIONS
At the initial evaluation, the patient was prescribed the following
medications: Metoprolol 25mg BID, Phenytoin 300mg qHS and
KCL 10mEq daily.
DIAGNOSTIC IMPRESSION AND CLINICAL SEVERITY
After undergoing a structured clinical interview utilizing MINI
International Neuropsychiatric Interview, the patient met DSM
IV-TR diagnostic criteria for an adjustment disorder with mixed
anxiety and depressed mood. We assessed the degree of sever-
ity of the patient’s symptoms using several quantitative clinical
measures. These indicated “severe” levels of general anxiety (via
BAI) and borderline clinical depression (via Beck Depression
Inventory, BDI) (Beck and Steer, 1993) (Table 3).
TREATMENT COURSE
The patient underwent a neurology consultation including EEG,
to evaluate the possibility of a seizure disorder. The EEG was
conducted with the patient in the awake and asleep states.
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Hyperventilation and photic stimulation were not performed as
activating maneuvers, and no sedation was given. While maxi-
mally awake, the posterior dominant rhythm was 9–10Hz, which
was symmetric, synchronous and reactive to eye opening and
eye closure. Three brief periods of high amplitude theta activity
(4–7Hz) were captured and reported as paroxysmal in nature.
They appeared generalized, without a focal cortical distribu-
tion, lasting approximately 1–2 s. These slowings occurred in the
wakeful and/or drowsy state, with no evidence of epileptiform
behaviors at the time. They were interpreted as potentially con-
sistent with physiological drowsiness. In one instance the slowing
appeared notched, which could indicate possible epileptiform
activity. However, as a fast alpha variant was present at the same
time, it was considered suggestive against an epileptic etiology.
Vertex waves signifying drowsiness were noted later in the record-
ing, but not at the time of the paroxysmal slowing. This was also
considered suggestive against an ictal semiology. Overall, the EEG
was judged to be normal in wakefulness and stage II sleep, with-
out any clear electrographic features of seizure. No epileptiform
behaviors were identified during clinical observation.
Despite the lack of clear electrographic evidence of a seizure
disorder the periods of high amplitude generalized slowing and
the reported phenomenology of her episodes were felt to be
possibly consistent with a seizure disorder. Seizure prophylaxis
was continued, but switched from Phenytoin to Levetiracetam
1000mg BID.
After further consultation, the patient elected to undergo
BCSD. The resection covered the lower half of the stellate gan-
glion and the bodies of sympathetic chain from T2 through
T4. Discharge medications included Levetiracetam 1000mg BID
and Propranolol 40mg TID. Evaluation of the patient’s symp-
tom scores at 1 month post-BCSD revealed clinically significant
decreases in depression (via BDI), anxiety (via BAI) and shock
catastrophizing (via SCS) (Figure 4). Clinical evaluation at 1
FIGURE 3 | Time Course of greatest reductions in Beck anxiety
symptoms following BCSD in Case 1. Palpitations and dizziness were the
largest reductions reported after BCSD. The largest magnitude reduction
overall was feeling scared, which had fully decreased by 3 months, after the
patient had begun Cognitive Behavioral Therapy. Scale: 0 = “Not at all.”
1 = “Mildly, but it didn’t bother me that much.” 2 = “Moderately—it wasn’t
pleasant at times.” 3 = “Severely—it bothered me a lot.” Note: ratings for
dizzy/lightheaded and faint/lightheaded were identical and overlapping.
month post-BCSD, revealed that she had not experienced any
further shocks, and no further ICD events had been detected.
The patient the patient reported her mood and anxiety symptoms
were much improved. She declined the recommendation to seek
further psychiatric follow up, and as she was subsequently lost to
follow-up no further psychometric data are available.
AUTONOMIC TESTING
Psychophysiological measures
Continuous measures of skin conductance level (SCL), systolic
blood pressure (SBP), and diastolic blood presssure (DBP) were
recorded during psychophysiological assessment using Biopac
MP150 hardware and Acqknowledge 4.3 software (Biopac, Santa
Barbara, CA). Two isotonic 1-cm diameter gel electrodes were
attached to the thenar and hypothenar eminence of the subject’s
nondominant hand to assess SCL. This tonic measure of gal-
vanic skin resistance was selected as a measure of sympathetic
arousal due the prolonged time intervals examined (Naqvi and
Bechara, 2006). Blood pressure was continuously assessed using
the CNAP 500 Monitor (CN Systems, Graz, Austria) with finger
cuffs, which were placed between the proximal and distal inter-
phalangeal joints of the third and fourth digits of the subject’s
nondominant hand. Heart rate was not examined due to the pres-
ence of atrial pacing in both patients, which kept the heart rate
constant.
Laboratory procedures
The psychophysiological assessment began with a 5-min rest-
ing baseline during which the subject was seated in a chair
and instructed to remain at rest and minimize movement.
Psychophysiological measures (SCL, SBP, and DBP) were assessed
during the 5-min baseline. As the pre-BCSD testing occurred in
an inpatient setting, the first 2min of the 5-min baseline period
were discarded in order to account for possible environment-
related influences on autonomic tone. Data for each measure for
the final 3min was averaged to provide a baseline value for that
session. Additional interventions to reduce outside distraction
included closing the door of the patient’s single occupancy room,
and silencing the alarms of monitoring equipment. The resting
FIGURE 4 | Time Course of Psychiatric symptom ratings for Case 2
during 1 month follow up.
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baseline period was followed by 3 tasks in the following order: a
valsalva task, a handgrip task, and a mental arithmetic task.
Valsalva task
The valsalva task involved performing two sustained valsalva
maneuvers while in a seated position. The subject was given the
following instructions, “During this task, I will place my hand on
your abdomen. The goal is to push my hand away as far as you
can by protruding your abdomen. Hold this position for as long as
you can. Remember to keep breathing while bearing down.” The
procedure was demonstrated by the assessor, practiced once by
the subject, and then performed twice by the subject. Each trial
period lasted approximately 15–25 s. Psychophysiological mea-
sures were assessed during the two valsalva trials, and scores on
SCL, SBP, and DBP were averaged across the two trials.
Handgrip task
The isometric handgrip task involved a hand dynamometer held
by the subject’s dominant hand. The following instructions were
provided before performing the task, “During this task you will
squeeze a hand dynamometer for 2min at a specific grip strength
level with your dominant hand. I will first determine your maxi-
mum grip strength level by asking you to squeeze the dynamometer
with as much force as possible.” Following determination of sub-
ject’s maximum grip strength, the dial on the dynamometer was
placed at 30% of the maximum grip strength, and the subject was
instructed to squeeze the grip at that level for 2minutes. Values
on SCL, SBP, and DBP were averaged across this 2-min period.
Mental arithmetic
The mental arithmetic task was selected as a cognitive stressor
and adapted from the Trier Social Stress Task (Kirschbaum et al.,
1993). This modified protocol consisted of a 5-min period during
which the subject was instructed to consecutively subtract by 13’s
starting at 1022, in front of two experimenters. The subject was
told to perform this task aloud as quickly and accurately as pos-
sible, was corrected each time an error was committed, and then
told to start over at 1022. Mean SCL, SBP, and DBP were assessed
across the 5-min period.
Data processing
Acqknowledge software, version 4.3, was used to process all
data collected during the psychophysiological assessment ses-
sions. Using Acqknowledge, SCL was averaged across the pre-
specified 2min resting baseline and specified periods during each
task described above. The Acqknowledge blood pressure classi-
fier analysis feature was used to identify SBP and DBP at each
heartbeat. Means for SBP and DBP were determined for resting
baseline and for specified periods during each task. This study was
approved by the Unversity of California Los Angeles Institutional
Review Board, and all participants provided informed consent
prior to participation.
Results
Mean values of the autonomic testing in Case 2 are displayed
in Table 4. Figures 5–7 show changes in each measure from
the resting baseline value pre- and post-BCSD. Compared with
Table 3 | Psychiatric symptom ratings for Case 2 during 1 month
follow-up.
Scale Pre BCSD 1 month post
BDI (max 63) 19* 5
BAI (max 63) 27* 15*
PCL civilian (max 85) 38* 35*
SCS (max 52) 28* 7
*Indicates scores in a clinically significant range based on scoring criteria for
each instrument. BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory;
PDSS, Panic Disorder Severity Scale; PCL, PTSD Checklist—Civilian version.
SCS, Shock Catastrophizing Scale; FSAS, Florida Shock Assessment Scale.
Table 4 | Mean measures of systolic blood pressure (SBP), diastolic
blood pressure (DBP) and skin conductance level (SCL) during
baseline, valsalva maneuver, isometric handgrip and mental
arithmetic stressor, before and after BCSD in Case 2.
Pre/ Post Task Normal Beats PVCs SBP DBP SCL
Count Count mmHg mmHg µS
Pre Baseline 309 0 114 79 1.31
Post Baseline 305 0 118 85 0.23
Pre Valsalva 47 0 136 73 2.28
Post Valsalva 30 0 106 67 0.35
Pre Handgrip 134 0 131 70 2.75
Post Handgrip 129 0 111 73 0.39
Pre Arithmetic 310 0 110 80 4.56
Post Arithmetic 325 0 119 83 0.41
PVC, premature ventricular contraction; µS, microsiemens.
before BCSD, the patient demonstrated clear declines in base-
line adjusted systolic and diastolic blood pressure response for
the valsalva and handgrip tasks, but less so with the mental
arithmetic stressor, which did not show robust changes at either
time point. Comparing pre- vs. post-BCSD, the patient demon-
strated prominent declines in baseline adjusted SCL for all tasks
(Figure 7).
DISCUSSION
To our knowledge, Case 1 represents the first reported synergis-
tic combination of BCSD with multimodal psychiatric treatment
resulting in successful management of anxiety related to recur-
rent ICD shocks. The combination of BCSD, cognitive behavioral
psychotherapy and pharmacotherapy was sufficient to attenu-
ate the patient’s clinical symptoms and maladaptive behaviors,
with resulting improvements in work, home and role func-
tioning that were maintained at 1 year. Despite these clinically
significant improvements, not all of the patient’s symptoms
resolved. He continued to experience cognitive threat appraisals
on a frequent basis, although these were no longer incapaci-
tating. He also continued to avoid some activities such as vig-
orous exercise or sexual activity, due to concerns of incurring
another shock.
With Case 2, we examined the effect of BCSD on emo-
tional state and autonomic tone. To assess autonomic tone, we
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FIGURE 5 | Mean changes in systolic blood pressure from baseline
during autonomic challenge before and after bilateral cardiac
sympathetic decentralization (BCSD) in Case 2.
FIGURE 6 | Mean changes in diastolic blood pressure from baseline
during autonomic challenge before and after bilateral cardiac
sympathetic decentralization (BCSD) in Case 2.
chose tasks that have been previously shown to directly acti-
vate the medial visceromotor network, which includes the ACC
and medial prefrontal cortex (Shoemaker et al., 2012). Compared
with before BCSD, we observed robust attenuated sympathetic
responses to the valsalva and handgrip tasks, but less so with
the mental arithmetic stressor. The patient’s lack of autonomic
response to this latter task at both time points could explained
by several factors, including failure to elicit mental stress due to
decreased task difficulty, decreased effort (Brehm and Self, 1989)
or due to low trait anxiety in the patient (Gramer and Saria,
2007). Reductions in autonomic responses have been reported
following partial sympathectomy in patients with familial hyper-
hidrosis, including decreased systolic and diastolic blood pressure
responses to positional change (Kingma et al., 2002) and dur-
ing exertion (Nakamura et al., 2002), providing further evidence
for the efficacy of this procedure in attenuating sympathetic
responses.
The presence of a potential seizure disorder in Case 2 raises
interesting questions about the possible impact of an epileptic
focus in the brain on the patient’s cardiac arrhythmia (Leung
et al., 2006; Sevcencu and Struijk, 2010; Marynissen et al., 2012).
However, the lack of testing for ictal autonomic semiology during
FIGURE 7 | Mean changes in skin conductance level from baseline
during autonomic challenge before and after bilateral cardiac
sympathetic decentralization (BSCD) in case 2. µS, microsiemens.
the EEG and lack of examination of the relationship between the
paroxysmal slowing and EKG changes limits interpretation of a
linking relationship between these conditions.
SIGNIFICANCE
We interpret Case 1’s positive response to multidisciplinary treat-
ment in the context of our recently proposed “ABC” model of
anxiety (Bystritsky et al., 2013). This model describes a set of
processes and underlying brain regions that interact in a cycli-
cal manner to produce anxiety that can generate a variety of
anxiety disorders, depending on numerous influences including
context, genetics, and environment. In the model, A stands for
“Alarm,” defined as emotions, sensations or physiological reac-
tions to perceived threatening situations; B stands for “Belief,”
defined as the process of attributing meaning or relevance to
the experienced emotions and sensations; C stands for “Coping”
response, defined as the specific behaviors or mental activity
aimed at reducing anxiety and avoiding the perceived danger. In
Case 1, after undergoing BCSD the patient reported attenuated
Alarm sensations and physiological responses (e.g., decreased
heart rate, decreased heartbeat sensation), despite the presence
of the same physical and mental triggers. This alone was insuf-
ficient to attenuate his anxiety, likely because he continued to
impute these triggers and sensations with dangerous meaning
(i.e., Beliefs). Once he began engaging in the psychotherapeu-
tic work that CBT requires of patients (particularly relaxation
exercises to further decrease Alarm, cognitive restructuring to
reorganize the Belief system, and exposure and response preven-
tion to elicit fear extinction learning), he was able to improve
his Coping and change the cycle of his anxiety from a maladap-
tive to an adaptive state. Though this significantly attenuated his
anxiety and panic symptoms, he finally achieved an optimum
response when this approach was augmented with serotonergic
medication. The greater magnitude of Case 1’s anxiety symptoms
as compared with Case 2 may have been due to a combination
of factors including severity (number of shocks received), dura-
tion (greater than 3 years vs. less than 1 year), and differences in
genetic and environmental predisposition to experiencing anxiety
and distress.
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In Case 2 we also observed clinically significant decreases
in depression, anxiety and shock catastrophizing following
BCSD. This data yields a preliminary hypothesis that the BCSD
procedure itself may have a positive impact on mood and anxiety
in these patients beyond simply decreasing arrhythmias, ICD
shock frequency or reducing autonomic responses to mental
and physical stressors. Indeed, partial sympathectomy has been
applied as a treatment for several decades in medical disorders
with high mortality rates (Schwartz et al., 1991), low mortality
rates (Hashmonai et al., 2000), as well as for affective disturbances
(Drott et al., 2002) (but see Crozier (2003) for a discussion of
the downsides of this latter approach). Such invasive approaches
should never be undertaken lightly, and should only be consid-
ered after careful examination of the potential risks and extensive
discussion with a patient who possesses decision-making capac-
ity. Given the life threatening nature of ventricular arrhythmias,
the profound dysfunction that can occur following recurrent ICD
shocks, and the repeatedly observed links between emotional
stress and ventricular fibrillation (Reich et al., 1981; Lampert
et al., 2000; Ziegelstein, 2007), further study appears warranted to
explore this hypothesis. Longitudinal comparison with patients
who do not undergo BCSD (but who also receive CBT and/or
medication management) will be an important comparison, in
order to better understand the specificity of the interventions
employed in both Cases. Additional studies appear warranted
to identify which patient based predictors (e.g., psychological
testing, psychiatric diagnosis, autonomic responsiveness) will be
most helpful in selecting the optimal combination of treatment
approaches.
We noticed that focused reassurance by Case 1’s cardiologist
during the initial implantation stage appeared to attenuate a spe-
cific set of symptoms: fear of death during ICD shock. While
provision of reassurance is normally considered maladaptive dur-
ing psychotherapeutic treatment of primary anxiety disorders,
this particular form seemed to enhance the patient’s coping
response when under the acute duress of receiving a train of
shocks. In the context of the ABC model, it appears that this
information (i.e., knowledge from cardiologist that “ICD shocks
will not kill you”) combined flexibly with his Belief system so
that the shocks were not interpreted as dangerously, enabling
him to remain relatively calm. Although repeated reassurance can
quickly lead to maladaptive safety seeking (as in the aforemen-
tioned ICD patient who slept in the hospital for fear of leaving and
being shocked), we highlight this instance as it is likely reflective
of a broader practice when patients are counseled during the pre-
implantation process. If this type of intervention is prominently
recalled by patients, then perhaps additional psychoeducation
interventions can be employed to help facilitate prompter recov-
ery efforts in patients. Such interventions have been proposed in
the past (Sears and Conti, 2003), and systematic pre-implantation
interventions have recently been proposed by larger organiza-
tions such as the American Heart Association (Dunbar et al.,
2012). These proposed interventions are supported by random-
ized controlled trials that provide important empirical evidence
that patients with ICDs can benefit from CBT even in the absence
of BCSD (Chevalier et al., 2006; Irvine et al., 2011).
In Case 1, we observed a decrease in reported aversive intero-
ceptive sensations, particularly of palpitations, following BCSD.
Although this is a preliminary finding restricted to retrospective
report in a single patient, this raises interesting teleological ques-
tions about the neurophysiological plausibility of such an effect.
That is, how would partial sympathectomy result in decreased
cardiac interoceptive awareness, and which peripheral and cen-
tral neural systems are important in this process? Does decreased
efferent noradrenergic signaling to the heart following BCSD
result in decreased heart rate, stroke volume and pulse pressure,
and thereby affect afferent interoceptive signaling to body sensi-
tive brain regions, such as the insula and somatosensory cortex?
(Khalsa et al., 2009a,b; Gazzola et al., 2012). Given the promi-
nent cortical representation of cardiovascular impulses during
physical and mental stress (Pollatos and Schandry, 2004; Gray
et al., 2007), what are the central neural consequences of BCSD?
Are visceromotor signals from the ACC and medial prefrontal
cortex, key drivers of autonomic efferent signaling (Shoemaker
et al., 2012), altered by BCSD? Beyond a role for the stellate
ganglion in afferent interoceptive information transmission, how
does this region result in the modulation of emotional experience
observed in both cases? Does bilateral interruption of these fibers
provide a linking mechanism between the observed improve-
ments in mortality (Ajijola et al., 2012; Vaseghi et al., 2013)
and brain networks mediating autonomic functioning, stress,
and emotional experience (Lane and Jennings, 1995; Critchley
et al., 2005; Lane et al., 2011)? Put more simply, when corti-
cal visceral sensory and motor regions are less bombarded by
peripheral information, does this “calm” the brain and decrease
ventricular excitability? These and many more questions await
investigation.
CONCLUSION
Collectively, these preliminary findings suggest that an integra-
tive, multidisciplinary cardiovascular and psychiatric approach to
treating ventricular arrhythmias and severe recurrent ICD shocks
can result in sustained improvements in physical, psychological
and ultimately functional status. The relative roles of psychoedu-
cation, CBT, medication management and BCSD deserve further
careful consideration and discussion prior to application in a
larger scale.
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APPENDIX
Shock Castastrophizing Scale (SCS). Adapted from the Pain
Catastrophizing Scale (Sullivan et al., 1995). Scores range from
0 to 52. Crohnbach’s alpha coefficient = 0.914, number of
items= 13, number of ICD patients completing = 10.
Not at all To a slight degree To a moderate degree To a great degree All the time
I worry all the time about whether the
shock will end
0 1 2 3 4
I feel I can’t go on 0 1 2 3 4
It’s terrible and I think it’s never going to
get any better
0 1 2 3 4
It’s awful and I feel that it overwhelms me 0 1 2 3 4
I feel I can’t stand it anymore 0 1 2 3 4
I become afraid that the shocks will get
worse
0 1 2 3 4
I keep thinking of other painful events 0 1 2 3 4
I anxiously want the shocks to go away 0 1 2 3 4
I can’t seem to keep it out of my mind 0 1 2 3 4
I keep thinking about how much it hurts 0 1 2 3 4
I keep thinking about how badly I want the
shocks to stop
0 1 2 3 4
There’s nothing I can do to reduce the
intensity of the shocks
0 1 2 3 4
I wonder whether something serious may
happen
0 1 2 3 4
SHOCK CATASTROPHIZING SCALE
We are interested in the types of thoughts and feeling that you have
when you think about being shocked by your defibrillator. Using the
scale, please indicate the degree to which you have these thoughts
and feelings when you anticipate being shocked.
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